Eprenetapopt (GMP)

Eprenetapopt (GMP) (APR-246 (GMP) ) is Eprenetapopt in GMP grade. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Eprenetapopt (APR-246) is a first-in-class, small molecule that restores wild-type p53 functions in TP53-mutant cells. Eprenetapopt triggers apoptosis in tumor cells. Eprenetapopt also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance[1][2][3].

5291-32-7

APR-246 (GMP) ; PRIMA-1Met (GMP)

12352005

Apoptosis; Autophagy; Ferroptosis; MDM-2/p53

Apoptosis; Autophagy

Cancer-programmed cell death

Cancer

O=C1C(COC)(CO)N2CCC1CC2

C10H17NO3

199.25

[1]Peng X, et al. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. Cell Death Dis. 2013 Oct 24;4:e881|[2]Stuber G, et al. PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein. Mol Cancer. 2009 Mar 26;8:23.|[3]Sallman DA, et al. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. J Clin Oncol. 2021;39 (14) :1584-1594.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-19980G/

GMP Small Molecules

Phase 3